E-mail this page | Print this page



Title: Antimonopoly Bodies Study the Market of Innovative Medicines 
Author: Russia Pharmaceuticals & Healthcare Practice Group 
Contact Information: Olga Ordenova 
Publication Date: August  2008  
Publication Type: Newsletter/Alert 
Practice/Industry: Pharmaceuticals & Healthcare; Tax
Region: Europe, Middle East & Central Asia
Office: Moscow/Russia
Description: According to a report of the Federal Antimonopoly Service of Russia (hereinafter “FAS”) posted on its website on 5 August 2008, FAS has begun an analysis of the Russian market for innovative medicines designated for seven principal areas of treatment (myeloleukemia, enzymopathy, pituitary nanism, haemophilia, disseminated sclerosis, mucviscidosis, and transplantation). 
Price and Currency: Complimentary
Publication/Link: English     Russian